Target intelligence / Profile preview

Microbial transformation of metalloids

Molecular classification
Other
01

Overview

Microbial transformation of metalloids refers to the complex series of biochemical reactions—including oxidation, reduction, methylation, and demethylation—performed by microorganisms to process elements such as arsenic, selenium, and antimony (Gadd, 2010). These transformations allow microbes to utilize metalloids as electron donors or acceptors for energy, or to convert toxic ions into less harmful or volatile forms as a survival mechanism (Rosen, 2002). Within the human body, the gut microbiota significantly contributes to the biotransformation of ingested metalloids, which can profoundly alter their bioavailability and systemic toxicity (Sun et al., 2022). While certain transformations serve as detoxification, others can produce highly reactive intermediates, such as monomethylarsonous acid, which are more toxic than the parent compounds (NIH). Although not a traditional pharmacological target, this process is a critical area of study in toxicology and environmental bioremediation, as it directly influences the development of diseases like arsenicosis and various cancers (PubMed; Wikipedia).

Other names
Microbial metalloid metabolismBiotransformation of metalloidsMicrobial redox of metalloidsMicrobial metalloid detoxification
02

Mechanism of action

Not applicable; this is a broad biological process rather than a specific molecular drug target.

03

Biological functions

DetoxificationMetabolic processOxidoreductase activityBiogeochemical cyclingMethylationVolatilization
04

Disease associations

ToxicityCancerInfectionArsenicosis
05

Safety considerations

Production of highly toxic trivalent methylated intermediatesInterspecies variability in gut microbial composition affecting toxin metabolismEnvironmental mobilization of toxic metalloid species into the food chain
06

Biomarkers

Urinary arsenic levelsBlood selenium concentrationPresence of microbial arsM (arsenite methyltransferase) genePresence of microbial aioA (arsenite oxidase) geneMonomethylarsonous acid (MMA III) levels in excreta

Beyond the preview

Go deeper on Microbial transformation of metalloids.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Microbial transformation of metalloids.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call